These findings suggest that NALCN variants influence channel function in diverse ways and that differences in mutation location contribute to the variability in clinical severity observed across CLIFAHDD cases. This evidence concerns the gene NALCN and congenital contractures of the limbs and face, hypotonia, and developmental delay.